These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18001077)

  • 1. Design of a tumor-homing cell-penetrating peptide.
    Myrberg H; Zhang L; Mäe M; Langel U
    Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transtumoral targeting enabled by a novel neuropilin-binding peptide.
    Roth L; Agemy L; Kotamraju VR; Braun G; Teesalu T; Sugahara KN; Hamzah J; Ruoslahti E
    Oncogene; 2012 Aug; 31(33):3754-63. PubMed ID: 22179825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
    Mizejewski GJ; Eisele L; Maccoll R
    Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
    Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
    J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific peptides for the therapeutic targeting of oncogenes.
    Privé GG; Melnick A
    Curr Opin Genet Dev; 2006 Feb; 16(1):71-7. PubMed ID: 16377176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide.
    Gellerman G; Baskin S; Galia L; Gilad Y; Firer MA
    Anticancer Drugs; 2013 Feb; 24(2):112-9. PubMed ID: 23187462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer activity of targeted pro-apoptotic peptides.
    Ellerby HM; Arap W; Ellerby LM; Kain R; Andrusiak R; Rio GD; Krajewski S; Lombardo CR; Rao R; Ruoslahti E; Bredesen DE; Pasqualini R
    Nat Med; 1999 Sep; 5(9):1032-8. PubMed ID: 10470080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery.
    Cordova A; Woodrick J; Grindrod S; Zhang L; Saygideger-Kont Y; Wang K; DeVito S; Daniele SG; Paige M; Brown ML
    Bioconjug Chem; 2016 Sep; 27(9):1981-90. PubMed ID: 26965452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
    Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
    Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity.
    Liang JF; Yang VC
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5071-5. PubMed ID: 16168650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
    Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
    J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.
    Vallespi MG; Fernandez JR; Torrens I; Garcia I; Garay H; Mendoza O; Granadillo M; Falcon V; Acevedo B; Ubieta R; Guillen GE; Reyes O
    J Pept Sci; 2010 Jan; 16(1):40-7. PubMed ID: 19908203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimer display of tumor-homing peptides.
    Lempens EH; Merkx M; Tirrell M; Meijer EW
    Bioconjug Chem; 2011 Mar; 22(3):397-405. PubMed ID: 21261269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein delivery by the cell-penetrating peptide YTA2.
    Myrberg H; Lindgren M; Langel U
    Bioconjug Chem; 2007; 18(1):170-4. PubMed ID: 17226970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.